| |
|
|
|
Akari Therapeutics Plc  
|
|
4.1 0.04 (0.01%) |
03-22 16:00 |
|
Open: |
3.99 |
Pre close: |
4.06 |
Target:
|
7.43
|
|
High: |
4.299 |
Low: |
3.85 |
Resistance:
|
6.36
9.20
|
|
Volume: |
537,719 |
Market Cap: |
65M |
Support:
|
1.76
1.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.27
 |
MACD |
MACD(12,26):
|
0.67  |
|
MA(20): |
2.95 |
Signal(12,26,9): |
0.54 |
|
MA(100): |
2.05 |
Stochastic Oscillator |
%K(14,3):
|
31.28 |
|
MA(250): |
2.01 |
%D(3): |
33.24 |
|
Average Volume(K) |
3-Month: |
201097
|
52-Week |
High:
|
9.20 |
|
10-Days: |
1194446 |
Low: |
1.56 |
|
RSI |
RSI(14):
|
61.79 |
Change(%): |
118.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.420 |
Return on Equity (ttm) |
-259.2 |
Shares Out. (M) |
15.81 |
|
EPS Est. Current Year |
-2.360 |
Return on Assets (ttm) |
-143.1 |
Shares Float (M) |
14.49 |
|
EPS Est. Next Year |
-3.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.60 |
|
EPS Est. Next Quarter |
-0.660 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.10 |
|
Forward EPS |
-1.938 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
14.550 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.76 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.28 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-20.21 |
P/CF |
-2.44 |
|
|
|
|
|
|
